Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Lerner

Showing results (331-340 of 375) with videos related to

Pageof 38
Sort By:
International Psychogeriatrics|March 14, 2025
Correlation between changes in apathy and cognition in Alzheimer's disease associated apathy: Analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)Krushnaa Sankhe, Shankar Tumati, Jamie Perin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisLauren A Cruz, Shiying Liu, Kristy L Miskimen, et al.
Science Signaling|March 6, 2014
KCNQ1, KCNE2, and Na+-coupled solute transporters form reciprocally regulating complexes that affect neuronal excitabilityGeoffrey W Abbott, Kwok-Keung Tai, Daniel L Neverisky, et al.
The Clinical Neuropsychologist|September 2, 2021
Robust demographically-adjusted normative data for the Montreal Cognitive Assessment (MoCA): Results from the systolic blood pressure intervention trialBonnie C Sachs, Gordon J Chelune, Stephen R Rapp, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 29, 2023
Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 TrialKrista L Lanctôt, Luc Rivet, Shankar Tumati, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 14, 2017
Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT)Daniel E Weiner, Sarah A Gaussoin, John Nord, et al.
International Psychogeriatrics|January 11, 2026
Peripheral biomarkers associated with apathy and predicting response to methylphenidate: Secondary analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET2) studyKrushnaa Sankhe, Myuri Ruthirakuhan, Ana C Andreazza, et al.
Genomics|March 1, 1997
Genomic structure and complete nucleotide sequence of the Batten disease gene, CLN3H M Mitchison, P B Munroe, A M O'Rawe, et al.
Journal of Alzheimer'S Disease : JAD|December 8, 2020
Lower Levels of Education Are Associated with Cognitive Impairment in the Old Order AmishJairo Ramos, Aneesa R Chowdhury, Laura J Caywood, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2021
Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)Nicholas M Pajewski, Fanny M Elahi, Manjula Kurella Tamura, et al.
Pageof 38

Showing results (331-340 of 375) with videos related to

Sort By:
Pageof 38
International Psychogeriatrics|March 14, 2025
Correlation between changes in apathy and cognition in Alzheimer's disease associated apathy: Analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET 2)Krushnaa Sankhe, Shankar Tumati, Jamie Perin, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisLauren A Cruz, Shiying Liu, Kristy L Miskimen, et al.
Science Signaling|March 6, 2014
KCNQ1, KCNE2, and Na+-coupled solute transporters form reciprocally regulating complexes that affect neuronal excitabilityGeoffrey W Abbott, Kwok-Keung Tai, Daniel L Neverisky, et al.
The Clinical Neuropsychologist|September 2, 2021
Robust demographically-adjusted normative data for the Montreal Cognitive Assessment (MoCA): Results from the systolic blood pressure intervention trialBonnie C Sachs, Gordon J Chelune, Stephen R Rapp, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|June 29, 2023
Heterogeneity of Response to Methylphenidate in Apathetic Patients in the ADMET 2 TrialKrista L Lanctôt, Luc Rivet, Shankar Tumati, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 14, 2017
Cognitive Function and Kidney Disease: Baseline Data From the Systolic Blood Pressure Intervention Trial (SPRINT)Daniel E Weiner, Sarah A Gaussoin, John Nord, et al.
International Psychogeriatrics|January 11, 2026
Peripheral biomarkers associated with apathy and predicting response to methylphenidate: Secondary analysis of the Apathy in Dementia Methylphenidate Trial 2 (ADMET2) studyKrushnaa Sankhe, Myuri Ruthirakuhan, Ana C Andreazza, et al.
Genomics|March 1, 1997
Genomic structure and complete nucleotide sequence of the Batten disease gene, CLN3H M Mitchison, P B Munroe, A M O'Rawe, et al.
Journal of Alzheimer'S Disease : JAD|December 8, 2020
Lower Levels of Education Are Associated with Cognitive Impairment in the Old Order AmishJairo Ramos, Aneesa R Chowdhury, Laura J Caywood, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 17, 2021
Plasma amyloid beta, neurofilament light chain, and total tau in the Systolic Blood Pressure Intervention Trial (SPRINT)Nicholas M Pajewski, Fanny M Elahi, Manjula Kurella Tamura, et al.
Pageof 38